In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase
Crossref DOI link: https://doi.org/10.1007/s11030-021-10215-5
Published Online: 2021-03-25
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Celik, Ismail http://orcid.org/0000-0002-8146-1663
Erol, Meryem
Duzgun, Zekeriya
Text and Data Mining valid from 2021-03-25
Version of Record valid from 2021-03-25
Article History
Received: 30 November 2020
Accepted: 21 March 2021
First Online: 25 March 2021
Free to read: This content has been made available to all.